GlassScriptPhysician profile
Sanam E Campbell
NPI 1558345272
$2,489.67
in general payments reported to CMS, 2019-2025
21 companies · $40.38 in 2025
The $40.38 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $141 · 2021: $205 · 2022: $1,432 · 2023: $217 · 2024: $70.44 · 2025: $40.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $327.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,170.37 | 2022 | |
| Abbvie INC. | $405.61 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $183.33 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $108.90 | 2019-2025 | |
| Therapeuticsmd, INC. | $94.32 | 2019-2022 | |
| Avion Pharmaceuticals | $87.62 | 2020-2022 | |
| Pfizer INC. | $79.22 | 2019-2024 | |
| Myovant Sciences INC. | $61.10 | 2021-2022 | |
| Organon LLC | $41.23 | 2022 | |
| Exeltis, USA INC. | $32.06 | 2022 | |
| Merz North America, INC. | $32.00 | 2019 | |
| Axonics, INC. | $28.12 | 2023-2024 | Axonics |
| Duchesnay USA Incorporated | $25.98 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.46 | 2019-2020 | |
| Roche Diagnostics Corporation | $21.34 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $18.59 | 2023 | Myfembree |
| Mayne Pharma Commercial LLC | $15.83 | 2022 | |
| Intuitive Surgical, INC. | $15.82 | 2021 | |
| Shield Therapeutics INC | $15.40 | 2023 | Accrufer |
| Minerva Surgical, INC | $15.07 | 2019 | |
| Merck Sharp & Dohme LLC | $13.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanam Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.